Demographic, clinical, immunological, and molecular features of iranian national cohort of patients with defect in DCLRE1C gene
Authors:
- Soodeh GhadimiSGSoodeh Ghadimi
- Mahnaz JameeMJMahnaz Jamee
- Hassan AbolhassaniHAHassan Abolhassani
- Nima ParvanehNPNima Parvaneh
- Nima RezaeiNRNima Rezaei
- Samaneh DelavariSDSamaneh Delavari
- Mahnaz Sadeghi-ShabestariMSMahnaz Sadeghi-Shabestari
- Sedigheh Rafiei TabatabaeiSTSedigheh Rafiei Tabatabaei
- Alireza FahimzadAFAlireza Fahimzad
- Shahnaz ArminSAShahnaz Armin
- Zahra ChavoshzadehZCZahra Chavoshzadeh
- Samin SharafianSSSamin Sharafian
Open Access
- 21 February 2023
- journal article
- research article
- Published by Springer Nature in Allergy, Asthma & Clinical Immunology
- Vol. 19 (1) , 1-12
Abstract
Background: DCLRE1C gene mutation leads to Artemis deficiency, a severe form of combined immunodeficiency (SCID). Impaired DNA repair and block in early adaptive immunity maturation results in T-B-NK+ immunodeficiency associated with radiosensitivity. Recurrent infections early in life are the main characteristic of Artemis patients. Method: Among 5373 registered patients, 9 Iranian patients (33.3% female) with confirmed DCLRE1C mutation were identified since 1999–2022. The demographic, clinical, immunological and genetic features were collected through retrospective investigation of medical records and using next generation sequencing. Results: Seven patients were born in a consanguineous family (77.8%). The median age of onset was 6.0 (5.0–17.0) months. Severe combined immunodeficiency (SCID) was clinically detected at a median (IQR) age of 7.0 (6.0–20.5) months, following a median diagnostic delay of 2.0 (1.0–3.5) months The most typical first presentation was pneumonia (44.4%) and otitis media (3.33%), followed by BCG lymphadenitis (22.2%) and gastroenteritis (11.1%). The most prevalent manifestations were respiratory tract infections (including otitis media) (66.6%) and chronic diarrhea (66.6%). In addition, juvenile idiopathic arthritis (P5) and celiac disease and idiopathic thrombocytopenic purpura (P9) as autoimmune disorders were reported in 2 patients. All patients had reduced B CD19+ and CD4+ cell counts. IgA deficiency occurred in 77.8% of individuals. Conclusion: Recurrent infections particulary respiratory tract infection and chronic diarrhea during the first months of life in patients born to consanguineous parents should raise the suspicion for inborn errors of immunity, even in the presence of normal growth and development.Keywords
This publication has 34 references indexed in Scilit:
- Radiation-sensitive severe combined immunodeficiency: The arguments for and against conditioning before hematopoietic cell transplantation—what to do?Journal of Allergy and Clinical Immunology, 2015
- DCLRE1C(ARTEMIS) mutations causing phenotypes ranging from atypical severe combined immunodeficiency to mere antibody deficiencyHuman Molecular Genetics, 2015
- Functional analysis of naturally occurring DCLRE1C mutations and correlation with the clinical phenotype of ARTEMIS deficiencyJournal of Allergy and Clinical Immunology, 2015
- Successful newborn screening for SCID in the Navajo NationClinical Immunology, 2015
- SCID patients with ARTEMIS vs RAG deficiencies following HCT: increased risk of late toxicity in ARTEMIS-deficient SCIDBlood, 2014
- The many faces of Artemis-deficient combined immunodeficiency — Two patients with DCLRE1C mutations and a systematic literature review of genotype–phenotype correlationClinical Immunology, 2013
- DNA repair: the link between primary immunodeficiency and cancerAnnals of the New York Academy of Sciences, 2011
- Two SCID cases with Cernunnos‐XLF deficiency successfully treated by hematopoietic stem cell transplantationPediatric Transplantation, 2011
- Frequency and Clinical Manifestations of Patients with Primary Immunodeficiency Disorders in Iran: Update from the Iranian Primary Immunodeficiency RegistryJournal of Clinical Immunology, 2006
- Bone marrow transplantation for T−B− severe combined immunodeficiency disease in Athabascan-speaking native AmericansBone Marrow Transplantation, 2001